Your session is about to expire
← Back to Search
Smoked Cannabis Effects Study (S-TACOFS Trial)
S-TACOFS Trial Summary
This trial will study how different doses of inhaled cannabis with varying amounts of THC and CBD affects the body, as well as how long THC can be detected in oral fluid.
S-TACOFS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowS-TACOFS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 46 Patients • NCT03008005S-TACOFS Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- If you have a Body Mass Index (BMI) between 18.5 and 34 kg/m2, you are considered to be within the healthy weight range.My doctor has checked my health history and found no issues with using cannabis.I take medication daily or weekly, not including birth control.I have used cannabis once a week or less in the past month.You have a moderate to severe addiction to marijuana or any other drugs except nicotine and caffeine, according to the DSM-V criteria.You have used illegal drugs, except for cannabis, in the last 4 weeks.I am not taking any medications that could interfere with the study.I have or had a lung or breathing problem.I can attend the study in Westwood (Los Angeles) between 9 AM - 4 PM on weekdays.I have a chronic condition like pain, anxiety, depression, or diabetes.I am a man or a woman not pregnant or breastfeeding, aged 21-55.I can participate in all required study activities.I am a man or a woman not pregnant or breastfeeding, aged 21-55.You have any other mental health condition.You are not getting treatment for your use of cannabis.You are not currently receiving treatment for using cannabis.
- Group 1: Placebo
- Group 2: 20 mg THC
- Group 3: 20 mg CBD + 20 mg THC
- Group 4: 20 mg CBD
- Screening: It may take up to 2 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 1 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 0 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical benefits can be obtained from consuming a combination of 20 mg CBD and 20 mg THC Cannabis?
"A combination of 20 mg CBD and 20 mg THC Cannabis may be prescribed to ameliorate weight loss, inadequate response to conventional therapy, and pharmacotherapy."
Do I satisfy the requirements to participate in this medical experiment?
"This study requires 22 persons with a history of drug abuse ranging from 21 to 55 years old. Participants should have an BMI between 18.5 and 34kg/m2, not actively seek treatment for cannabis use, and be either male or non-pregnant & non-lactating females."
Are there any vacancies for participants in this trial?
"According to clinicaltrials.gov, the research team is presently recruiting participants for this study which was published on June 1st 2022 and last updated 8 days later."
Could you please elucidate the results of any prior investigations involving cannabis that had a dosage combination of 20 mg CBD and 20 mg THC?
"At the present moment, 64 medical studies are actively investigating 20 mg CBD + 20 mg THC Cannabis with 8 trials in Phase 3. Belmont, Massachusetts is one of 132 sites hosting these experiments."
What is the current patient population for this medical study?
"Affirmative. The clinicaltrial.gov website attests that this medical research, originally posted on June 1st 2022 is actively recruiting participants. 22 individuals are required at a single site to complete the trial."
Is admission to this investigation restricted to individuals aged 18 or older?
"The criteria for enrolment in this trial dictates that applicants must be aged between 21 and 55."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of California, Los Angeles: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger